• Pol II Degradation Triggers Cell Death Independently of Tran

  2026-04-20

  This study uncovers that targeted degradation of RNA polymerase II induces cell death through mechanisms separate from transcriptional shutdown. These findings challenge current models of apoptosis induction in tumor cells and suggest new strategies for leveraging transcriptional machinery disruption in cancer research.

• Sulfamonomethoxine: Mechanisms and Strategy for Translationa

  2026-04-20

  Explore how Sulfamonomethoxine (SMM) advances translational research at the interface of veterinary infection control, aquaculture, and environmental biotransformation. This thought-leadership article integrates mechanistic insights, recent experimental findings, and strategic guidance for researchers seeking robust, evidence-driven workflows.

• RNA Pol II Inhibition Triggers Apoptosis via Pol IIA Loss, N

  2026-04-19

  Harper et al. (2025) reveal that cell death following RNA polymerase II inhibition is driven by an active apoptotic signaling response to loss of the hypophosphorylated Pol IIA form, rather than passive mRNA decay. This insight clarifies mechanistic ambiguities in cell death pathways relevant to cancer research and therapeutic strategies.

• Chemical Genetic Dissection of Jasmonate Signaling Using Bes

  2026-04-18

  This study demonstrates that Bestatin (Ubenimex), a selective aminopeptidase inhibitor, can be used as a chemical genetic probe to dissect jasmonate signaling in Arabidopsis. The findings reveal how Bestatin activates jasmonate-responsive genes and identifies novel genetic loci involved in plant defense and development.

• A 83-01: Potent ALK-5 Inhibitor for TGF-β Pathway Research

  2026-04-17

  A 83-01 is a selective ALK-5 inhibitor that potently blocks TGF-β-induced signaling, enabling precise modulation of Smad-dependent transcription. This small molecule tool is validated for epithelial-mesenchymal transition (EMT) research and cellular growth inhibition assays, with robust selectivity and high purity confirmed by analytical techniques.

• 10058-F4 C-Myc-Max Dimerization Inhibitor: Advanced Workflow

  2026-04-16

  10058-F4, a potent c-Myc-Max dimerization inhibitor from APExBIO, empowers researchers to dissect transcriptional control, apoptosis, and telomerase regulation in oncology and stem cell models. This guide translates the latest mechanistic breakthroughs and experimental benchmarks into actionable protocols, comparative insights, and troubleshooting strategies for acute myeloid leukemia and prostate cancer research.

• GM 6001 (Galardin): Next-Generation MMP Inhibition in Cellul

  2026-04-15

  Explore how GM 6001 (Galardin) is redefining research on matrix metalloproteinase inhibition, with a focus on advanced cellular repair, meniscal healing research, and modulation of cancer signaling. This cornerstone article offers unique protocol insights and cross-disciplinary perspectives.

• Unleashing Cy3-dCTP for Direct Enzymatic DNA Labeling Precis

  2026-04-14

  Cyanine 3-dCTP empowers direct, high-efficiency fluorescent labeling of DNA and cDNA, streamlining complex workflows from PCR to in situ hybridization. See how APExBIO's optimized Cy3-dCTP delivers quantifiable sensitivity, robust polymerase compatibility, and workflow-ready flexibility for advanced genomics.

• Novobiocin: Aminocoumarin Antibiotic for Antiparasitic Resea

  2026-04-13

  Novobiocin is a research-grade aminocoumarin antibiotic with robust antiparasitic and antibacterial properties. It acts primarily as a DNA gyrase and Hsp90 inhibitor, showing efficacy in vitro and in vivo against key pathogens. Quantitative benchmarks support its use in advanced resistance studies and apoptosis assays.

• HotStart™ Universal 2X Green qPCR Master Mix: Precision in O

  2026-04-13

  Explore how HotStart Universal 2X Green qPCR Master Mix elevates real-time PCR gene expression analysis for oncology biomarker discovery. This article uniquely connects advanced product chemistry with translational insights from FGFR2 fusion-driven cholangiocarcinoma research.

• AEBSF.HCl in Lysosomal Protease Targeting: Translational Imp

  2026-04-12

  Explore how AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) enables precise, irreversible control of lysosomal serine protease activity in advanced cell death and neurodegeneration research. This article uniquely dissects decision-making for translational assay design, bridging recent mechanistic breakthroughs with practical protocol guidance.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-04-12

  This study reveals that increasing GLT-1 expression in astrocytes attenuates neuronal apoptosis and cognitive dysfunction following traumatic brain injury (TBI) by inhibiting the CB1-CREB signaling pathway. The findings clarify how endocannabinoid signaling, specifically elevated 2-AG levels, suppresses GLT-1 and exacerbates glutamate excitotoxicity, highlighting new therapeutic avenues targeting glutamate homeostasis.

• Naftifine HCl: Optimizing Allylamine Antifungal Research Wor

  2026-04-11

  Naftifine HCl streamlines research into fungal cell membrane disruption by reliably inhibiting squalene 2,3-epoxidase. Discover protocol-driven strategies, troubleshooting tips, and translational insights that empower your antifungal studies with APExBIO's high-purity allylamine antifungal agent.

• HotStart™ 2X Green qPCR Master Mix: Technical Protocol Guide

  2026-04-11

  HotStart™ 2X Green qPCR Master Mix addresses specificity and reproducibility challenges in SYBR Green-based real-time PCR, particularly for gene expression analysis, RNA-seq validation, and nucleic acid quantification workflows. It is not suited for probe-based detection or applications requiring multiplexing beyond SYBR Green’s capabilities.

• Apatinib (YN968D1): Technical Guidance for Angiogenesis Assa

  2026-04-10

  Apatinib (YN968D1) is a selective oral VEGFR-2 tyrosine kinase inhibitor used in cancer research to evaluate angiogenesis inhibition and tumor growth suppression. It is best suited for in vitro and in vivo models investigating VEGF signaling pathways, but is not recommended for studies requiring water-soluble compounds or untested cross-kinase selectivity. This article outlines laboratory best practices and practical protocol parameters.

11730 records 1/782 page Next 12345 下5页 Last page